Header links
Intranet
Donate now
image/svg+xml Map
Contact us

General finder

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Ensayo fase III, aleatorizado, doble ciego para evaluar el efecto de balcinrenona/dapagliflozina, en comparación con dapagliflozina, sobre el riesgo de eventos de insuficiencia cardiaca y muerte cardiovascular en pacientes con insuficiencia cardíaca y función renal alterada

Contact

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

ESTUDIO EN FASE IIIB SIN ENMASCARAMIENTO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DEL TRATAMIENTO CON LEBRIKIZUMAB EN ADULTOS Y ADOLESCENTES CON DERMATITIS ATÓPICA DE MODERADA A GRAVE.

Contact
  • Protocol code: M-17923-34
  • EudraCT code: No aplica
  • Pathology: Tumors
  • Principal investigator:  Aparicio Español, Gloria
  • Service: Dermatologia
  • Phase: Phase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.

Contact

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults with IgA Nephropathy

Contact
  • Protocol code: CHK02-02
  • EudraCT code: No aplica
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Agraz Pamplona, Irene
  • Research group:  Nefrologia i trasplantament renal
  • Service: Nefrologia
  • Phase: Phase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A Multi-center, Randomized, Double-blind, Placebo-controlled Trial toEvaluate the Neurological Effects of EryDex on subjects with Ataxia Telangiectasia

Contact

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of NMD670 Over 21 Days Ambulatory Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease

Contact
  • Protocol code: NMD670-02-0003
  • EudraCT code: No aplica
  • Pathology: Nervous system diseases
  • Principal investigator:  Juntas Morales, Raul
  • Research group:  Sistema nerviós perifèric
  • Service: Neurologia
  • Phase: Phase II
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Effects of NNC0194-0499 alone and in combination with semaglutide, of semaglutide alone, and of cagrilintide alone and in combination with semaglutide on liver damage and alcohol use in people with alcohol-related liver disease

Contact
  • Protocol code: NN9500-7730
  • EudraCT code: No aplica
  • Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified
  • Principal investigator:  Ventura Cots, Meritxell
  • Research group:  Malalties hepàtiques
  • Service: Hepatologia
  • Phase: Phase II
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect ofEDG-5506 on Safety, Biomarkers, Pharmacokinetics, and Functional Measures in Adults andAdolescents with Becker Muscular Dystrophy

Contact
  • Protocol code: EDG-5506-201
  • EudraCT code: No aplica
  • Pathology: Nervous system diseases
  • Principal investigator:  Juntas Morales, Raul
  • Research group:  Peripheral Nervous System
  • Service: Neurology
  • Phase: Phase II
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Microbiology
Descripció
Project Manager-Microbiology Research Group_20240292
Codi
2024-292
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0292//2024_0292_001.pdf
Reclutant
Actiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Clinical Neuroimmunology
Descripció
Predoctoral Researcher Clinical Neuroimmunology Group_20240293
Codi
2024-293
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0293//2024_0293_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Animal Caretaker_20240287
Codi
2024-287
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0287//2024_0287_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Neurodegenerative Diseases
Descripció
Clinical Researcher Neurodegenerative Diseases Group_20240288
Codi
2024-288
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0288//2024_0288_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Neurodegenerative Diseases
Descripció
Clinical Researcher Neurodegenerative Diseases Group_20240889
Codi
2024-289
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0289//2024_0289_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Neurodegenerative Diseases
Descripció
Study Coordinator Neurodegenerative Diseases Group _20240290
Codi
2024-290
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0290//2024_0290_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Physiology and Pathophysiology of the Digestive Tract
Descripció
Bioinformatics technician_20240291
Codi
2024-291
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0291//2024_0291_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Childhood Cancer and Blood Disorders
Descripció
Post-graduate Researcher_20240285
Codi
2024-285
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0285//2024_0285_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Research Technician_20240286
Codi
2024-286
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0286//2024_0286_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Laboratory Assistant_20240280
Codi
2024-280
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0280//2024_0280_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Study Coordinator_20240281
Codi
2024-281
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0281//2024_0281_001.pdf
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Data Entry_20240282
Codi
2024-282
URL Document vinculat
http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0282//2024_0282_001.pdf
Reclutant
Inactiu